Pharma Circle Panel
Devin Swanson
Principal Scientist, Johnson & Johnson
At Johnson & Johnson Innovative Medicine, we are leading where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way.
• 23 years of experience in the pharmaceutical industry.
• Expertise in medicinal chemistry, drug discovery, neuroscience, immunology, and intellectual property.
• Work history covering eleven programs across the neuroscience, pain, and immunology therapeutic areas. Six programs have successfully advanced small molecules into clinical development including one Phase 3, one Phase 2, and one Phase 1 ready asset.
• Former CTL (chemistry team lead) with track record of successful people and project management.
• Top tier MBA with emphasis on finance and valuation.
• Finance, business development, due diligence, and external innovation experience.
• Effectively communicates with and understands the perspective of both the science and business professional.
• Published author, inventor, and speaker (15 manuscripts (5 first author), 15 patent applications – issued patents).
• Interested in evaluating, championing, and commercializing innovative science.